XML 62 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHAREHOLDERS' EQUITY
 3 Months Ended
Mar. 31, 2014
Stockholders' Equity Note [Abstract]  
SHAREHOLDERS' EQUITY
SHAREHOLDERS’ EQUITY
 
Valeant Pharmaceuticals International, Inc. Shareholders
 
 
 
 
 
Common Shares
 
Additional
Paid-In
Capital
 
Accumulated
Deficit
 
Accumulated
Other
Comprehensive
Loss
 
Valeant
Pharmaceuticals
International, Inc.
Shareholders’
Equity
 
Noncontrolling
Interest
 
Total
Equity
 
Shares
 
Amount
 
 
 
 
 
 
Balance, January 1, 2013
303.9

 
$
5,940.7

 
$
267.1

 
$
(2,371.0
)
 
$
(119.4
)
 
$
3,717.4

 
$
—

 
$
3,717.4

Common shares issued under share-based compensation plans
0.4

 
11.6

 
(9.0
)
 
—

 
—

 
2.6

 
—

 
2.6

Repurchase of common shares
(0.5
)
 
(9.8
)
 
—

 
(25.2
)
 
—

 
(35.0
)
 
—

 
(35.0
)
Share-based compensation
—

 
—

 
9.1

 
—

 
—

 
9.1

 
—

 
9.1

Employee withholding taxes related to share-based awards
—

 
—

 
(6.8
)
 
—

 
—

 
(6.8
)
 
—

 
(6.8
)
Tax benefits from stock options exercised
—

 
—

 
4.6

 
—

 
—

 
4.6

 
—

 
4.6

 
303.8

 
5,942.5

 
265.0

 
(2,396.2
)
 
(119.4
)
 
3,691.9

 
—

 
3,691.9

Comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
—

 
—

 
—

 
(27.5
)
 
—

 
(27.5
)
 
—

 
(27.5
)
Other comprehensive loss
—

 
—

 
—

 
—

 
(77.4
)
 
(77.4
)
 
—

 
(77.4
)
Total comprehensive loss
 
 
 
 
 
 
 
 
 
 
(104.9
)
 
—

 
(104.9
)
Balance, March 31, 2013
303.8

 
$
5,942.5

 
$
265.0

 
$
(2,423.7
)
 
$
(196.8
)
 
$
3,587.0

 
$
—

 
$
3,587.0

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2014
333.0

 
$
8,301.2

 
$
228.8

 
$
(3,278.5
)
 
$
(132.8
)
 
$
5,118.7

 
$
114.6

 
$
5,233.3

Common shares issued under share-based compensation plans
0.5

 
15.0

 
(11.5
)
 
—

 
—

 
3.5

 
—

 
3.5

Share-based compensation
—

 
—

 
24.8

 
—

 
—

 
24.8

 
—

 
24.8

Employee withholding taxes related to share-based awards
—

 
—

 
(27.7
)
 
—

 
—

 
(27.7
)
 
—

 
(27.7
)
Tax benefits from stock options exercised
—

 
—

 
1.2

 
—

 
—

 
1.2

 
—

 
1.2

Acquisition of noncontrolling interest
—

 
—

 
(1.1
)
 
—

 
—

 
(1.1
)
 
(2.2
)
 
(3.3
)
 
333.5

 
8,316.2

 
214.5

 
(3,278.5
)
 
(132.8
)
 
5,119.4

 
112.4

 
5,231.8

Comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
—

 
—

 
—

 
(22.6
)
 
—

 
(22.6
)
 
2.3

 
(20.3
)
Other comprehensive loss
—

 
—

 
—

 
—

 
(7.2
)
 
(7.2
)
 
(0.8
)
 
(8.0
)
Total comprehensive loss
 
 
 
 
 
 
 
 
 
 
(29.8
)
 
1.5

 
(28.3
)
Balance, March 31, 2014
333.5

 
$
8,316.2

 
$
214.5

 
$
(3,301.1
)
 
$
(140.0
)
 
$
5,089.6

 
$
113.9

 
$
5,203.5